229 related articles for article (PubMed ID: 6572972)
1. Regulation of the pro-opiomelanocortin mRNA levels in rat pituitary by dopaminergic compounds.
Chen CL; Dionne FT; Roberts JL
Proc Natl Acad Sci U S A; 1983 Apr; 80(8):2211-5. PubMed ID: 6572972
[TBL] [Abstract][Full Text] [Related]
2. Concomitant dopaminergic and glucocorticoid control of pituitary proopiomelanocortin messenger ribonucleic acid and beta-endorphin levels.
Autelitano DJ; Clements JA; Nikolaidis I; Canny BJ; Funder JW
Endocrinology; 1987 Nov; 121(5):1689-96. PubMed ID: 2959468
[TBL] [Abstract][Full Text] [Related]
3. Chronic haloperidol treatment increases the level of in vitro translatable messenger ribonucleic acid coding for the beta-endorphin/adrenocorticotropin precursor proopiomelanocortin in the pars intermedia of the rat pituitary.
Höllt V; Haarmann I; Seizinger BR; Herz A
Endocrinology; 1982 Jun; 110(6):1885-91. PubMed ID: 6280978
[TBL] [Abstract][Full Text] [Related]
4. Role of dopamine in the regulation of proopiomelanocortin (POMC) mRNA levels in the arcuate nucleus and pituitary gland of the female rat as studied by in situ hybridization.
Tong Y; Pelletier G
Brain Res Mol Brain Res; 1992 Sep; 15(1-2):27-32. PubMed ID: 1331668
[TBL] [Abstract][Full Text] [Related]
5. Concomitant up-regulation of proopiomelanocortin and dopamine D2-receptor gene expression in the pituitary intermediate lobe of the spontaneously hypertensive rat.
Autelitano DJ; van den Buuse M
J Neuroendocrinol; 1997 Apr; 9(4):255-62. PubMed ID: 9147288
[TBL] [Abstract][Full Text] [Related]
6. Dopamine inhibition of proopiomelanocortin gene expression in the intermediate lobe of the pituitary. Interactions with corticotropin-releasing factor and the beta-adrenergic receptors and the adenylate cyclase system.
Loeffler JP; Demeneix BA; Kley NA; Höllt V
Neuroendocrinology; 1988 Feb; 47(2):95-101. PubMed ID: 2963967
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of haloperidol on the rat pituitary: decreased biosynthesis, processing and release of anterior lobe pro-opiomelanocortin.
Meador-Woodruff JH; Pellerito B; Bronstein D; Lin HL; Ling N; Akil H
Neuroendocrinology; 1990 Mar; 51(3):294-303. PubMed ID: 2109273
[TBL] [Abstract][Full Text] [Related]
8. Biosynthesis and processing of pro-opiomelanocortin-derived peptides during fetal pituitary development.
Allen RG; Pintar JE; Stack J; Kendall JW
Dev Biol; 1984 Mar; 102(1):43-50. PubMed ID: 6321277
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid regulation of pro-opiomelanocortin gene transcription in the rat pituitary.
Eberwine JH; Roberts JL
J Biol Chem; 1984 Feb; 259(4):2166-70. PubMed ID: 6546571
[TBL] [Abstract][Full Text] [Related]
10. Differential influence of haloperidol and sulpiride on dopamine receptors and peptide mRNA levels in the rat striatum and pituitary.
Jaber M; Tison F; Fournier MC; Bloch B
Brain Res Mol Brain Res; 1994 Apr; 23(1-2):14-20. PubMed ID: 7518029
[TBL] [Abstract][Full Text] [Related]
11. Bromocriptine-induced changes in the biochemistry, physiology, and histology of the intermediate lobe of the rat pituitary gland.
Beaulieu M; Goldman ME; Miyazaki K; Frey EA; Eskay RL; Kebabian JW; Cote TE
Endocrinology; 1984 May; 114(5):1871-84. PubMed ID: 6325134
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation by glucocorticoids of proopiomelanocortin mRNA levels in the anterior and intermediate lobes of the rat pituitary.
Schachter BS; Johnson LK; Baxter JD; Roberts JL
Endocrinology; 1982 Apr; 110(4):1442-4. PubMed ID: 7060531
[TBL] [Abstract][Full Text] [Related]
13. Regulation of proopiomelanocortin gene expression in rat brain and pituitary as studied by in situ hybridization.
Pelletier G
Ann N Y Acad Sci; 1993 May; 680():246-59. PubMed ID: 8512219
[TBL] [Abstract][Full Text] [Related]
14. Coordinate regulation of peptide acetyltransferase activity and proopiomelanocortin gene expression in the intermediate lobe of the rat pituitary.
Millington WR; O'Donohue TL; Chappell MC; Roberts JL; Mueller GP
Endocrinology; 1986 May; 118(5):2024-33. PubMed ID: 2938933
[TBL] [Abstract][Full Text] [Related]
15. Dopamine regulates expression of the glandular-type kallikrein gene at the transcriptional level in the pituitary.
Pritchett DB; Roberts JL
Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5545-9. PubMed ID: 3475692
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoids regulate proopiomelanocortin gene expression in vivo at the levels of transcription and secretion.
Birnberg NC; Lissitzky JC; Hinman M; Herbert E
Proc Natl Acad Sci U S A; 1983 Nov; 80(22):6982-6. PubMed ID: 6316340
[TBL] [Abstract][Full Text] [Related]
17. Effects of selective D1- or D2-like dopamine receptor antagonists with acute "binge" pattern cocaine on corticotropin-releasing hormone and proopiomelanocortin mRNA levels in the hypothalamus.
Zhou Y; Spangler R; Yuferov VP; Schlussmann SD; Ho A; Kreek MJ
Brain Res Mol Brain Res; 2004 Nov; 130(1-2):61-7. PubMed ID: 15519677
[TBL] [Abstract][Full Text] [Related]
18. Detection and quantitation of pro-opiomelanocortin mRNA in pituitary and brain tissues from different species.
Civelli O; Birnberg N; Herbert E
J Biol Chem; 1982 Jun; 257(12):6783-7. PubMed ID: 6177687
[TBL] [Abstract][Full Text] [Related]
19. D-2 dopamine receptor-mediated inhibition of pro-opiomelanocortin synthesis in rat intermediate lobe. Abolition by pertussis toxin or activators of adenylate cyclase.
Cote TE; Felder R; Kebabian JW; Sekura RD; Reisine T; Affolter HU
J Biol Chem; 1986 Apr; 261(10):4555-61. PubMed ID: 3957908
[TBL] [Abstract][Full Text] [Related]
20. The mouse genome contains two nonallelic pro-opiomelanocortin genes.
Uhler M; Herbert E; D'Eustachio P; Ruddle FD
J Biol Chem; 1983 Aug; 258(15):9444-53. PubMed ID: 6308009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
